Ikarian Capital, LLC - ERYTECH PHARMA ownership

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ERYTECH PHARMA
ValueSharesWeighting
Q2 2023$2,257
-99.1%
3,019
-98.8%
0.00%
-100.0%
Q1 2023$252,111
+21175.2%
248,426
+8128.8%
0.06%
Q4 2022$1,185
-40.8%
3,0190.0%0.00%
Q3 2022$2,0003,0190.00%
Other shareholders
ERYTECH PHARMA shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 1,314,656$690,0000.03%
Vanguard Personalized Indexing Management, LLC 59,839$33,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,005$6,0000.00%
Asset Dedication, LLC 4,000$2,0000.00%
Ikarian Capital, LLC 3,019$2,0000.00%
UBS Group AG 4,320$2,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 10,590$6,0000.00%
Mariner, LLC 59,472$33,0000.00%
Citadel Advisors 18,181$10,0000.00%
View complete list of ERYTECH PHARMA shareholders